Strategic Integration GenDx is undergoing recent brand and product integrations, including CareDx Lab Products integration into GenDx, presenting a sales opportunity to cross-sell expanded service offerings and unified support for a broader customer base.

NGS and QPCR Expansion New NGS-based solutions and qPCR assays for individual HLA markers indicate potential upsell and bundling opportunities for existing customers seeking deeper HLA typing resolution and expanded companion diagnostics.

Training & Education Launch of hands-on training courses on HLA typing signals a channel for expanding customer engagement, upselling training packages, support contracts, and adoption of GenDx methodologies across labs.

Collaborative CDx Active collaborations to develop HLA-based companion diagnostics for cancer immunotherapies (e.g., PolyPEPI1018) open opportunities to partner with pharmaceutical and biotech customers seeking integrated testing and diagnostic solutions.

Global Reach With a global network of distributors and a mid-market revenue profile, GenDx presents scalable opportunities to expand into new labs and hospitals through distributor-led deployments and regional service contracts.